AVACOPAN
Manner of administration:Oral
Restriction
Indication: Anti-neutrophil cytoplasmic autoantibody (ANCA) associated vasculitis
Treatment phase: Induction treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 180 | # of repeats: 5 | DPMQ: $8,486.13 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Tavneos | |||||